Your browser doesn't support javascript.
loading
The impact of statin use on disease-related symptoms in patients with chronic myeloproliferative neoplasms.
Holik, Hrvoje; Lucijanic, Marko; Krecak, Ivan.
Affiliation
  • Holik H; Department of Internal Medicine, Dr. Josip Bencevic General Hospital, Slavonski Brod, Croatia.
  • Lucijanic M; Faculty of Medicine, University of Osijek, Osijek, Croatia.
  • Krecak I; Division of Hematology, University Hospital Dubrava, Zagreb, Croatia.
Ann Hematol ; 103(5): 1783-1785, 2024 May.
Article in En | MEDLINE | ID: mdl-38472363
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Myeloproliferative Disorders / Neoplasms Limits: Humans Language: En Journal: Ann Hematol / Ann. hematol / Annals of hematology Journal subject: HEMATOLOGIA Year: 2024 Document type: Article Affiliation country: Croacia Country of publication: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Myeloproliferative Disorders / Neoplasms Limits: Humans Language: En Journal: Ann Hematol / Ann. hematol / Annals of hematology Journal subject: HEMATOLOGIA Year: 2024 Document type: Article Affiliation country: Croacia Country of publication: Alemania